Health● LowOct 29 · Oct 29, 2026, 8:37 AM

Access to peptides eased despite FDA opposition

GlobeAlert Desk · curated from nwaonline · united states of america · North America

WASHINGTON -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development.

Read at nwaonline Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.

GlobeAlert context

What the desk knows about this story

Threat level

1 Low

Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.

Sources

1 publisher

Single-source so far. Treat details as unconfirmed until more publishers report.

More in Health

Health16m agoHe dies alone in the emergency room toiletRadio-Canada · Canada Health43m agoDJ Khaled shares he lost 90 pounds with help of GLP-1 drugThe Hill · United States Health44m agoWalkathon to raise awareness on diabetes heldThe Hindu Health44m agoChronic stress: what it is and how it affects the body, according to a specialistLa Nación · Argentina